Expression of the IL-10 gene in ITP patients compared to pediatric controls.

Pediatric controls, far left; total: results from all 18 patients. Group 1 indicates patients P1 to P12; group 2, patients P13 to P18; P13 to P16 patients with relapsing ITP; P17 and P18 patients with chronic ITP. Before Rx indicates at presentation; after Rx, 24 hours after IVIg therapy; follow-up, recall patients.